At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 278 enrolled
Drug / intervention
Bimatoprost 0.03% sterile solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence
In Brief
A Phase 3 clinical trial evaluating Bimatoprost 0.03% sterile solution and vehicle sterile solution for Eyelashes. Completed, enrolled 278 participants across 2 sites in 2 countries.
Detailed Summary
This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEyelashes
CountriesCanada, United States
Collaborators--
Timeline
Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
Primary CompletionOct 2007
Study CompletionDec 2007
First PostedJun 2008
TodayJul 2026
First PostedJun 9, 2008
Enrollment StartApr 1, 2007
Primary CompletionOct 1, 2007
Study CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.1 years ago
Interventions
Bimatoprost 0.03% sterile solutiondrug
Apply one drop of study medication using single-use per eye applicator to upper eyelid margin once daily.
vehicle sterile solutiondrug
Apply one drop of study medication using single-use per eye applicator to upper eyelid margin once daily